FundedIQ
Health Care

Cyclomics

Cyclomics is a Dutch startup with ambition is to transform cancer care by enabling faster and more reliable diagnoses, particularly in the context of cancer recurrence thanks to its proprietary circulating tumor DNA (ctDNA) detection technology. Accurate measurement of cancer recurrence and monitoring of treatment responses are important clinical needs in cancer diagnostics. The limitations of existing (imaging-based) methods poses a significant impediment to effective (re-)treatment and overall survival. The mission of Cyclomics is to address this challenge through an innovative solution for early cancer detection called CyclomicsSeq. This solution consists of a new diagnostic kit that can disrupt the cancer diagnostics market and clinical practice by enabling fast and reliable results, and delivering superior performance to standard radiological and/or physical examination alone. CyclomicsSeq's first application will be for head and neck cancers (HNC), where monitoring of treatment response and recurrence disease is essential for improving survival.

www.cyclomics.com Utrecht, The Netherlands 1-10 employees
Total raised
$3.0M
Rounds
1
Latest
Series Unknown
Jan 2026

Cyclomics is a Dutch startup with ambition is to transform cancer care by enabling faster and more reliable diagnoses, particularly in the context of cancer recurrence thanks to its proprietary circulating tumor DNA (ctDNA) detection technology. Accurate measurement of cancer recurrence and monitoring of treatment responses are important clinical needs in cancer diagnostics. The limitations of existing (imaging-based) methods poses a significant impediment to effective (re-)treatment and overall survival. The mission of Cyclomics is to address this challenge through an innovative solution for early cancer detection called CyclomicsSeq. This solution consists of a new diagnostic kit that can disrupt the cancer diagnostics market and clinical practice by enabling fast and reliable results, and delivering superior performance to standard radiological and/or physical examination alone. CyclomicsSeq's first application will be for head and neck cancers (HNC), where monitoring of treatment response and recurrence disease is essential for improving survival.

Cyclomics has raised $3.0M across 1 round. Its most recent round was a Series Unknown of $3.0M in Jan 2026. Full funding history, investors, and team are detailed below.

Funding history

1 round · 1 visible Unlock with FundedIQ

1 round on record.

Date
Round
Amount
Lead investor
Jan 7, 2026
Series Unknown
$3.0M

Unlock the lead investor and full details for this round.

Start 14-day free trial →

People

Unlock with FundedIQ

Founders, executives, and decision-makers — sourced and refreshed weekly.

Name
Role
LinkedIn

See who runs this company — founders and key execs, with titles, verified email addresses and LinkedIn profiles.

Start 14-day free trial →

Cyclomics is featured in

Similar companies

Teal Health

Teal Health is on a mission to empower women when it comes to their health – starting with at-home cervical cancer screenings. We believe that it’s time for women’s health to be designed for women, their preferences, and their experiences. With this in mind, Teal Health is creating the first FDA-approved at-home cervical cancer screening making it simple for a woman to stay current on this life-saving screening from the comfort, convenience, and privacy of her home. Through timely screenings, Teal health plans to eradicate cervical cancer in the US. Teal is backed by passionate and committed investors who share this important vision, including Felicis Ventures, Emerson Collective, Metrodora, and Serena Ventures.

Series A $18.3M
Livingston Hospital and Healthcare Services

Livingston Hospital and Healthcare Services Provide personalized, high-quality healthcare, responsive to the needs of the community.

Private Equity $5.0M
Arab Therapy

Arab Therapy functions as a startup that focuses on mental health.

Seed $2.0M
Bunker Kids

Bunker Kids is a startup that provides solutions optimized for achieving personal health goals using data and algorithms.

Series A $10.6M
Notable Systems

Notable Systems offers a health data platform that aims to revolutionize healthcare IT by making health data input and access more user-friendly. Their platform allows for easy data entry, passive data collection, seamless data access across various systems and organizations, and integration of different products via open API. This helps healthcare organizations efficiently capture and access health data.

Series B
Theradaptive

Theradaptive is a clinical-stage biologics company that is privately held and focused on developing protein therapeutics for spine, orthopedics, soft tissue repair, and targeted immuno-oncology. The company's innovative platform converts recombinant proteins into material-binding variants that can be used to coat implants, devices, and injectable carriers for various medical treatments. Theradaptive's lead candidate, OsteoAdapt SP™, is currently being evaluated in a Phase I/II clinical trial for degenerative disc disease, a condition that causes spinal joint deterioration and pain. This candidate combines Theradaptive's engineered protein AMP2™ with a synthetic bone graft to address this challenging medical issue.

Series Unknown $36.2M
QuantHealth

QuantHealth is an organization that produces software using artificial intelligence technology for drug development data. This software is utilized for conducting patient-focused medication simulations, with the aim of expediting and reducing the risks associated with drug development. By merging data from various sources within clinical and drug development fields, the company's software can forecast how patients will respond to both existing and innovative treatments. This enables pharmaceutical and biotechnology clients to conduct different versions of their clinical trials, enhancing trial design and boosting the chances of successful trials. As a result, QuantHealth aids in uncovering new clinical prospects and optimization strategies.

Series B $45.0M
Function Health

100 Healthy Years • Your new routine of 120+ advanced lab tests explained by the world's top doctors

Private Equity $450M
Sound Health

Sound Health utilizes acoustic resonance to offer relief for nasal issues. Their current offering is an app which scans the face to create a map of the bone structure, along with a headband that emits personalized frequencies for a 10-minute duration. The headband is readily available and the sound levels are comparable to using earbuds. The goal is for the headband to be easily attainable without a prescription, for the convenience of all patients.

Series A
Navi Medical Technologies

Navi Medical Technologies is a company that specializes in the development of medical devices.

Series Unknown $4.7M
Xeltis

The most cutting-edge polymer-based platform of restorative cardiovascular devices was created by Xeltis. When colonised by the patient's own tissue cells, Xeltis devices naturally transform into living blood arteries or heart valves. wwwxeltiscom

Series Unknown $23.3M
Throne

Throne is a health company that focuses on individual gut wellness and hydration maintenance.

Series A $10.0M
14-day free trial · Cancel anytime

Know who just raised. Then know who to reach.

Every newly funded startup with its round, its investors and its founders: delivered weekly by email, or searchable in the app.

Alerts from $19/mo · Pro from $99/mo. Card required, nothing charged until day 15, and we email you 3 days before that.